Respiratory distress syndrome

A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

뮤신-1 감소 화합물에 대한 고함량 검사를 통해 포스타마티닙이 COVID-19 대유행 기간 동안 급성 폐 손상에 대한 신속한 용도 변경을 위한 후보로 확인됨

Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes

SARS-CoV-2 감염 및 인간의 정량적 표현형에 관여하는 ACE2 및 TMPRSS2 유전자의 유전적 변이체 간의 연관성 부족

ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019

Severe COVID-19: A Review of Recent Progress With a Look Toward the Future

심각한 COVID-19: 미래를 내다보며 최근 진행 상황 검토

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

세포외 HMGB1: 코로나19를 포함한 중증 폐염증 치료 표적?

Severe acute respiratory distress syndrome in coronavirus disease 2019–infected pregnancy: obstetric and intensive care considerations

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy

COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial

DEXamethasone(CoDEX)으로 치료된 COVID-19 관련 ARDS: 무작위 시험에 대한 연구 설계 및 근거

Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series

COVID-19 치료를 위한 정맥 면역글로불린(Prevagen 또는 Octagam)의 사용: 후향적 사례 시리즈

Extracorporeal membrane oxygenation in acute respiratory distress syndrome due to influenza A (H1N1)pdm09 pneumonia. A single-center experience during the 2013-2014 season